Mainz Biomed Provides Year-End 2022 Corporate Review
03 janv. 2023 03h01 HE
|
Mainz BioMed NV
BERKELEY, US and MAINZ, Germany , Jan. 03, 2023 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the...
Mainz Biomed Enrolls First Patient in eAArly DETECT Study Evaluating Integration of Novel mRNA Biomarkers into ColoAlert
20 déc. 2022 03h01 HE
|
Mainz BioMed NV
Enrollment remains on track to complete in Q1 2023 with results in 1H 2023Potential to identify advanced adenomas, a type of pre-cancerous polyp often attributed to colorectal cancer (CRC) BERKELEY,...
Mainz Biomed Announces IRB Approval and Initiation of US Pivotal FDA Clinical Study
06 déc. 2022 03h01 HE
|
Mainz BioMed NV
ReconAAsense study examining the clinical performance of mRNA and DNA test combined with a fecal immunochemical test for early detection of advanced adenoma and colorectal cancer to enroll 15,000...
Mainz Biomed Appoints Amy Levin as Vice President of Regulatory Affairs to Oversee Global Regulatory Strategies
29 nov. 2022 08h00 HE
|
Mainz BioMed NV
BERKELEY, Calif. and MAINZ, Germany, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Mainz Biomed NV (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the...
Canon Medical Celebrates 30th Anniversary of Hybrid Angio-CT Technology with World’s First Deep Learning Spectral CT Reconstruction and HD 76 Technology Integration into Alphenix 4D CT System
28 nov. 2022 09h00 HE
|
Canon Medical Systems USA
Tustin, California, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Canon Medical Systems USA, Inc., a global leader in innovative diagnostic imaging technology, is proud to celebrate the 30th anniversary of...
Diagnostic Imaging Market Size is projected to reach USD 48 billion by 2029, with growth at a CAGR of 5.6% over the forecast period 2022-2029
23 nov. 2022 10h00 HE
|
DataM Intelligence
ENTERPRISE, Nevada, Nov. 23, 2022 (GLOBE NEWSWIRE) -- Diagnostic Imaging Market Size Share Growth Insights: According to the research report published by DataM Intelligence, the global Diagnostic...
Mainz Biomed to Participate in Deutsche Eigenkapitalforum and Cantor Fitzgerald’s Medical & Aesthetic Dermatology, Ophthalmology & MedTech Conference
22 nov. 2022 08h00 HE
|
Mainz BioMed NV
BERKELEY, Calif. and MAINZ, Germany, Nov. 22, 2022 (GLOBE NEWSWIRE) -- Mainz Biomed NV (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the...
Point of Care Ultrasound Market to hit USD 5.5 Billion by 2030, says Global Market Insights Inc.
22 nov. 2022 05h26 HE
|
Global Market Insights Inc.
Selbyville, Delaware, Nov. 22, 2022 (GLOBE NEWSWIRE) -- The point of care ultrasound market value is set to reach USD 5.5 billion by 2030, according to a new research report by Global Market...
Mainz Biomed Announces U.S. Extension of ColoFuture Study to Evaluate Integration of Novel mRNA Biomarkers into ColoAlert
15 nov. 2022 08h00 HE
|
Mainz BioMed NV
eAArly DETECT expected to complete enrollment in Q1 2023 with results in 1H 2023Enhances ColoFuture’s demographic profile and expedites data read-out timelinePotential to identify advanced adenomas, a...
[Latest] Global Respiratory Diagnostics Market Size/Share Worth USD 13.80 Billion by 2030 at an 8.5% CAGR: Custom Market Insights (Testing, Devices, Infection, Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth)
08 nov. 2022 11h58 HE
|
Custom Market Insights
Sandy, Utah, USA, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Respiratory Diagnostic Market Size, Trends and Insights By Product and Services...